American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Interactive Brokers
IBKR
|
+$222M |
| 2 |
Martin Marietta Materials
MLM
|
+$168M |
| 3 |
Fiserv
FI
|
+$123M |
| 4 |
VICI Properties
VICI
|
+$121M |
| 5 |
Reinsurance Group of America
RGA
|
+$120M |
Top Sells
| 1 |
Apple
AAPL
|
+$522M |
| 2 |
NVIDIA
NVDA
|
+$496M |
| 3 |
Microsoft
MSFT
|
+$317M |
| 4 |
Eli Lilly
LLY
|
+$273M |
| 5 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$231M |
Sector Composition
| 1 | Technology | 24.77% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Healthcare | 10.87% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLL
2726
DELISTED
Piedmont Lithium
PLL
| $150K | ﹤0.01% |
23,795
+11,270
| +90% | +$71K |
|
2727
Pliant Therapeutics
PLRX
$93.9M
| $149K | ﹤0.01% |
110,093
+9,244
| +9% | +$12.5K |
|
2728
Fossil Group
FOSL
$162M
| $148K | ﹤0.01% |
129,025
+100,783
| +357% | +$116K |
|
2729
CS Disco
LAW
$373M
| $145K | ﹤0.01% |
35,557
-114
| -0.3% | -$466 |
|
2730
TTEC Holdings
TTEC
$173M
| $144K | ﹤0.01% |
43,901
+7,393
| +20% | +$24.3K |
|
2731
Duluth Holdings
DLTH
$142M
| $143K | ﹤0.01% |
81,973
| – | – |
|
2732
4D Molecular Therapeutics
FDMT
$318M
| $141K | ﹤0.01% |
43,784
+4,999
| +13% | +$16.1K |
|
2733
Compass Therapeutics
CMPX
$633M
| $140K | ﹤0.01% |
+73,682
| New | +$140K |
|
2734
Larimar Therapeutics
LRMR
$339M
| $138K | ﹤0.01% |
64,284
+7,990
| +14% | +$17.2K |
|
2735
OptimizeRx
OPRX
$322M
| $137K | ﹤0.01% |
15,783
+1,387
| +10% | +$12K |
|
|
NAGE
2736
Niagen Bioscience, Inc. Common Stock
NAGE
$772M
| $136K | ﹤0.01% |
+19,676
| New | +$136K |
|
2737
Lantronix
LTRX
$189M
| $135K | ﹤0.01% |
54,318
+10,381
| +24% | +$25.8K |
|
2738
Burford Capital
BUR
$2.82B
| $134K | ﹤0.01% |
+10,174
| New | +$134K |
|
2739
Douglas Elliman
DOUG
$247M
| $131K | ﹤0.01% |
75,905
+19,300
| +34% | +$33.2K |
|
2740
Seer Inc
SEER
$115M
| $128K | ﹤0.01% |
76,001
-313
| -0.4% | -$529 |
|
2741
Semrush
SEMR
$1.11B
| $128K | ﹤0.01% |
+13,668
| New | +$128K |
|
2742
BlackSky Technology
BKSY
$699M
| $127K | ﹤0.01% |
+16,486
| New | +$127K |
|
2743
Sagimet Biosciences
SGMT
$207M
| $127K | ﹤0.01% |
38,831
+18,728
| +93% | +$61.1K |
|
2744
Gaotu Techedu
GOTU
$877M
| $126K | ﹤0.01% |
38,912
| – | – |
|
2745
Sight Sciences
SGHT
$184M
| $125K | ﹤0.01% |
52,282
+718
| +1% | +$1.72K |
|
2746
Star Holdings Shares of Beneficial Interest
STHO
$118M
| $122K | ﹤0.01% |
14,349
+918
| +7% | +$7.81K |
|
|
YRD
2747
Yiren Digital
YRD
$520M
| $121K | ﹤0.01% |
17,538
-4,796
| -21% | -$33K |
|
|
SVCO
2748
Silvaco Group
SVCO
$158M
| $120K | ﹤0.01% |
26,335
-6,122
| -19% | -$27.9K |
|
2749
Day One Biopharmaceuticals
DAWN
$735M
| $114K | ﹤0.01% |
+14,415
| New | +$114K |
|
2750
Assembly Biosciences
ASMB
$163M
| $113K | ﹤0.01% |
+11,799
| New | +$113K |
|